Connection

Julie Parsonnet to Seroepidemiologic Studies

Back to Details
This is a "connection" page, showing publications Julie Parsonnet has written about Seroepidemiologic Studies.
Julie Parsonnet
Connection Strength
0.108
Seroepidemiologic Studies
  1. Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic. JAMA Netw Open. 2021 07 01; 4(7):e2116572.
    View in: PubMed
    Score: 0.073
  2. Severe acute respiratory coronavirus virus 2 (SARS-CoV-2) seroprevalence in healthcare personnel in northern California early in the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol. 2021 09; 42(9):1053-1059.
    View in: PubMed
    Score: 0.018
  3. Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study. Lancet. 2020 10 24; 396(10259):1335-1344.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.